Most tri-county stocks fall as market sinks
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Tri-county stocks soar along with markets
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Tri-county stocks bounce back as market soars
The Dow Jones Industrial Average surged at historic rates March 24, as pressure came down from President Donald Trump on Congress to pass a fiscal stimulus bill and regulators to reopen businesses by Easter. Tri-county public companies rebounded 9.4 percent from the past week’s declines, including a 68 percent jump for Goleta breast implant supplier Read More →
Tri-county stocks mixed as stimulus package stalls
A 3 percent drop in U.S. equities markets hit smaller stocks in the Tri-Counties on March 23, as a stimulus package to combat the economic fallout of the coronavirus failed for a second time to gain legislative approval. The region’s companies had mixed results, with gains for eight out of the 10 largest firms. Goleta Read More →
Tri-county stocks end week with mixed results
Tri-county public companies ended the worst week for Wall Street since 2008 with a 5 percent drop March 20, as the threat of a recession loomed larger in the wake of the coronavirus outbreak. Stocks had a mixed close, with losses among several biotech firms, including regional biotech giant Amgen. Shares fell another 5.3 percent Read More →
Tri-county stocks bounce back from coronavirus losses
Tri-county stocks regained some of the previous day’s losses with the passage of a stimulus package to counteract the economic impacts of the coronavirus crisis, ending up 4.4 percent March 19 from the start of the week. Early stage biotech stocks topped the gains, including a 36 percent jump for Arcutis Biotherapeutics and a 27 Read More →